Exhibit 99.2 Arcadia Biosciences, Inc. Consolidated Balance Sheets (Unaudited) (In thousands, except share data) December 31, March 31, 2024 2023 Assets Current assets: Cash and cash equivalents $ 3,317 $ 6,518 Short-term investments 5,184 5,124 Accounts receivable and other receivables, net of allowance for doubtful accounts of $0 as of March 31, 2024 and December 31, 2023 760 514 Inventories — current 1,831 1,958 Assets held for sale 15 51 Prepaid expenses and other current assets 535 807 Total current as ...